PRESSEMITTEILUNGEN

– » Worldwide agreement for the use of certain Intercell’s AIP®-derived antigens to develop and commercialize animal vaccines » Intercell to receive upfront, option and milestone payments as well as royalties on product net sales ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company [...]

Continue reading

Adhoc, Animal Vaccines, Boehringer Ingelheim Vetmedica, Eans, Economical Power, Human Health, Human Vaccine, Intercell Ag, Milestone Payments, Net Sales, Novartis, Royalties, Strategic Partnership, Successful Technology, Today Announced That, Vaccine Candidates, Vaccine Company, Vaccine Targets, Vienna Austria, Worldwide Agreement

——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Research & Development 06.05.2010 Vienna (Austria), May 6, 2010 – Intercell AG (VSE: ICLL) today announced that it has signed an agreement with Cytos Biotechnology Ltd. to acquire Cytos’ [...]

Continue reading

Antibody Technology, B Cells, Cytos Biotechnology, D Technology, Discovery Activities, Disease Targets, Group B Streptococcus, Hospital Acquired Infections, Infectious Diseases, Intercell, Kyowa Hakko, Monoclonal Antibodies, Monoclonal Antibody, Platform Technology, Relevant Applications, Staphylococcus Aureus, Technology Platform, Technology Platforms, Vaccine Candidates, Vienna Austria

——————————————————————————– Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ——————————————————————————– New Products 30.03.2009 » U.S. FDA approves Intercell’s first marketed product, a new vaccine against Japanese Encephalitis for travelers and military personnel » Commercial product launch in the U.S. planned for Q2 2009 Vienna, Austria, March 30, [...]

Continue reading

Adhoc, Adult Travelers, Biotechnology Companies, Chief Executive Officer, Eans, Fda Approval, Food And Drug Administration, Food And Drug Administration Fda, India China, Initial Target, Intercell Ag, Japanese Encephalitis, Military Personnel, Novel Vaccine, Product Launch, S Market, Safe Way, Select Group, Vaccine Candidates, Vienna Austria